Literature DB >> 35041087

Long-term neurocognitive, psychological, and return to work outcomes in meningioma patients.

Angela Sekely1,2, Konstantine K Zakzanis3,4, Donald Mabbott4,5, Derek S Tsang6,7, Paul Kongkham8, Gelareh Zadeh8, Kim Edelstein3,9,10.   

Abstract

INTRODUCTION: This study aimed to investigate long-term neurocognitive, psychological, and return to work (RTW) outcomes in meningioma patients, and to explore whether neurocognitive and psychological factors influence RTW outcomes in this population.
METHODS: In this retrospective study, 61 meningioma patients completed in-depth clinical neuropsychological assessments. Of these participants, 42 were of working-age and had RTW information available following neuropsychological assessment. Seventy-one percent and 80% of patients received radiation and surgery, respectively, with 49% receiving both radiation and surgery. Associations between demographic, medical, neurocognitive, psychological, and RTW data were analyzed using multivariable logistic regression analyses.
RESULTS: In our sample, 68% of patients exhibited global neurocognitive impairment, with the largest effect sizes found on tests of visual memory (d = 0.73), executive function (d = 0.61), and attention (d = 0.54). Twenty-seven percent exhibited moderate to severe levels of depressive symptoms. In addition, 23% and 30% exhibited clinically significant state and trait anxiety, respectively. Forty-eight percent of patients were unable to RTW. Younger age, faster visuomotor processing speed, and, unexpectedly, higher trait anxiety scores were associated with an increased likelihood of returning to work.
CONCLUSIONS: Meningioma patients are at risk of experiencing neurocognitive deficits, psychological symptoms, and difficulties returning to work. Our results suggest that neurocognitive and psychological factors contribute to RTW status in meningioma patients. Prospective research studies are necessary to increase our understanding of the complexity of functional disability in this growing population.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Brain tumor; Meningioma; Neurocognition; Psychological symptoms; Return to work

Mesh:

Year:  2022        PMID: 35041087     DOI: 10.1007/s00520-022-06838-5

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.359


  22 in total

Review 1.  A biopsychosocial perspective on adjustment and quality of life following brain tumor: a systematic evaluation of the literature.

Authors:  Tamara Ownsworth; Anna Hawkes; Suzanne Steginga; David Walker; David Shum
Journal:  Disabil Rehabil       Date:  2009       Impact factor: 3.033

2.  Quality of life following surgery for intracranial meningiomas at Brigham and Women's Hospital: a study of 164 patients using a modification of the functional assessment of cancer therapy-brain questionnaire.

Authors:  S N Kalkanis; A Quiñones-Hinojosa; E Buzney; H J Ribaudo; P M Black
Journal:  J Neurooncol       Date:  2000-07       Impact factor: 4.130

Review 3.  Performance validity test failure in clinical populations-a systematic review.

Authors:  Laura McWhirter; Craig W Ritchie; Jon Stone; Alan Carson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-07-10       Impact factor: 10.154

Review 4.  Cognition and return to work after mild/moderate traumatic brain injury: A systematic review.

Authors:  Karthik Mani; Bryan Cater; Akshay Hudlikar
Journal:  Work       Date:  2017-09-14

Review 5.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

6.  International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.

Authors:  Jeffrey S Wefel; Janette Vardy; Tim Ahles; Sanne B Schagen
Journal:  Lancet Oncol       Date:  2011-02-25       Impact factor: 41.316

7.  Functional outcome and quality of life after meningioma surgery: a systematic review.

Authors:  Marco V Corniola; Torstein R Meling
Journal:  Acta Neurol Scand       Date:  2021-01-19       Impact factor: 3.209

8.  Prevalence of below-criterion Reliable Digit Span scores in a clinical sample of older adults.

Authors:  RyAnna Zenisek; Scott R Millis; Sarah J Banks; Justin B Miller
Journal:  Arch Clin Neuropsychol       Date:  2016-05-08       Impact factor: 2.813

9.  Late neurocognitive sequelae in patients with WHO grade I meningioma.

Authors:  M Dijkstra; D van Nieuwenhuizen; L J A Stalpers; M Wumkes; M Waagemans; W P Vandertop; J J Heimans; S Leenstra; C M Dirven; J C Reijneveld; M Klein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-07-24       Impact factor: 10.154

Review 10.  Cognitive functioning in meningioma patients: a systematic review.

Authors:  Ikram Meskal; Karin Gehring; Geert-Jan M Rutten; Margriet M Sitskoorn
Journal:  J Neurooncol       Date:  2016-04-05       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.